Cite
Sugimori C, Padron E, Caceres G, et al. Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation. Blood Cancer J. 2012;2(3):e63doi: 10.1038/bcj.2012.7.
Sugimori, C., Padron, E., Caceres, G., Shain, K., Sokol, L., Zhang, L., Tiu, R., O'Keefe, C. L., Afable, M., Clemente, M., Lee, J. M., Maciejewski, J. P., List, A. F., Epling-Burnette, P. K., & Araten, D. J. (2012). Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation. Blood cancer journal, 2(3), e63. https://doi.org/10.1038/bcj.2012.7
Sugimori, C, et al. "Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation." Blood cancer journal vol. 2,3 (2012): e63. doi: https://doi.org/10.1038/bcj.2012.7
Sugimori C, Padron E, Caceres G, Shain K, Sokol L, Zhang L, Tiu R, O'Keefe CL, Afable M, Clemente M, Lee JM, Maciejewski JP, List AF, Epling-Burnette PK, Araten DJ. Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation. Blood Cancer J. 2012 Mar;2(3):e63. doi: 10.1038/bcj.2012.7. Epub 2012 Mar 23. PMID: 22829258; PMCID: PMC3317526.
Copy
Download .nbib
